Frontiers Current Pharmacological Strategies for Duchenne

Stem Cell–Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Current management of Duchenne muscular dystrophy in the Middle East: expert report

Frontiers Drug development progress in duchenne muscular dystrophy

Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy: Molecular Therapy - Methods & Clinical Development

Current limitations of gene-targeted therapeutic strategies in DMD

Pharmacological strategies for muscular dystrophy

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

PDF] Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies